Researchers identify biomarkers for checkpoint inhibitor-induced hyperprogression of melanoma cells

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

Related Keywords

Tarek Haykal ,Balamayooran Theivanthiran ,Nagendra Yarla ,Aprilks Salama ,Michaelp Plebanek ,Y Van Nguyen ,Nicholasc Devito ,Alisha Holtzhausen ,April Salama ,Brent Hanks ,Linda Cao ,Michelle Ferreira ,National Institutes Of Health ,Duke Cancer Institute ,Duke Health ,Cancer Institute ,Science Translational ,Associate Professor ,Duke University School ,Rami Al Rohil ,National Institutes ,Biomarker ,Melanoma ,Dancer ,Drugs ,Immune System ,Immunotherapy ,Inflammasome ,Medicine ,Melanoma Cells ,Neck ,Humor ,